Madrigal Pharmaceuticals to Release First-Quarter 2025 Financial Results and Host Webcast on May 1, 2025GlobeNewsWire • 04/18/25
Madrigal Pharmaceuticals Announces Company Founder Rebecca Taub, M.D. to Become Senior Scientific and Medical Advisor; David Soergel, M.D.GlobeNewsWire • 04/16/25
Madrigal (MDGL) Up 0.5% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 03/28/25
Madrigal Pharmaceuticals: Rezdiffra First-Mover Advantage Gains Traction (Upgrade)Seeking Alpha • 02/28/25
Madrigal Q4 Earnings Beat, MASH Drug Sales Drive Top Line, Stock UpZacks Investment Research • 02/26/25
Madrigal Pharmaceuticals Stock Jumps On New Two-Year Data Showing Potential Benefit of Rezdiffra For Compensated Fatty Liver CirrhosisBenzinga • 02/26/25
Madrigal Pharmaceuticals Q4 Earnings Review: Strong Quarter, Even Stronger OutlookSeeking Alpha • 02/26/25
Madrigal Pharmaceuticals Reports Fourth-Quarter and Full-Year 2024 Financial Results and Announces New Two-Year Data Demonstrating Potential Benefit of Rezdiffra™ (resmetirom) in Patients with Compensated MASH CirrhosisGlobeNewsWire • 02/26/25
Madrigal Announces New Two-Year Data from the Compensated MASH Cirrhosis Arm of the MAESTRO-NAFLD-1 Trial Demonstrating Potential Benefit of Rezdiffra™ (resmetirom) in Patients with Compensated MASH CirrhosisGlobeNewsWire • 02/26/25
Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care ConferenceGlobeNewsWire • 02/21/25
Madrigal Pharmaceuticals to Release Fourth-Quarter and Full-Year 2024 Financial Results and Host Webcast on February 26, 2025GlobeNewsWire • 02/12/25
MDGL Stock Down 10% on Disappointing Preliminary Q4 Rezdiffra SalesZacks Investment Research • 01/15/25
Madrigal Pharmaceuticals Announces Preliminary* Fourth-Quarter and Full-Year 2024 Net Sales, Year-End Cash and Total Patients on RezdiffraGlobeNewsWire • 01/13/25
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the marketCNBC • 01/08/25
Madrigal Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/03/25